NEU 4.15% $13.61 neuren pharmaceuticals limited

just imagine for a moment that NNZ-2591 continues to show a...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 139 Posts.
    lightbulb Created with Sketch. 25
    just imagine for a moment that NNZ-2591 continues to show a positive effect on normalizing insulin levels and / or weight as some data has previously shown. Just imagine what that would be worth in addition to everything else!

    Holding very firmly & expecting positive announcement pre market on Monday followed by potential takeover offer. Would have been a very good reason to have issued the trading halt! All speculation of course however I do anticipate takeover offers in coming months at significant upside to current stock price ($35-40+). If results are lackluster, I expect a pullback to $12-15 range but will quickly rebound in 24’ as still undervalued on daybue earnings alone. GLTA.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.